A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)
Clinical trial NCT07710157 · RECRUITING
Trial details
- NCT number
- NCT07710157
- Sponsor
- Medical University Innsbruck
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-13
- Primary completion
- 2028-06-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.